Brevan Howard Capital Management’s Medpace MEDP Stock Holding History

Brevan Howard Capital Management’s Portfolio MEDP Stock Details MEDP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.47M	Buy	+2,773	New	+$1.28M	0.01%	875
2026 Q1	–	Sell	-1,946	Closed	-$996K	–	2344
2025 Q4	$1.09M	Sell	1,946 -5,295	-73%	-$3.01M	0.01%	725
2025 Q3	$3.72M	Sell	7,241 -5,070	-41%	-$2.21M	0.02%	319
2025 Q2	$3.86M	Buy	12,311 +8,241	+202%	+$2.47M	0.02%	465
2025 Q1	$1.24M	Buy	+4,070	New	+$1.37M	0.01%	427
2024 Q4	–	Sell	-861	Closed	-$287K	–	1282
2024 Q3	$287K	Buy	+861	New	+$327K	﹤0.01%	874
2024 Q1	–	Sell	-814	Closed	-$250K	–	1215
2023 Q4	$250K	Buy	+814	New	+$220K	﹤0.01%	797

Other funds holding MEDP

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Brevan Howard Capital Management's MEDP Position: Q2 2026 in Review

Brevan Howard Capital Management opened a new position in Medpace (MEDP) in Q2 2026: 2,773 shares worth $1.47M. The stake represents 0.01% of the portfolio and ranks #875 among its holdings. This is a return to the name: Brevan Howard Capital Management previously reported a position in MEDP as recently as Q4 2025.

Brevan Howard Capital Management first reported a position in MEDP in Q4 2023 and has held it in 7 quarters since. The position peaked at $3.86M in Q2 2025. 700 funds tracked by Wall St. Rank hold MEDP as of Q2 2026.

Brevan Howard Capital Management held 2,773 shares of Medpace worth $1.47M as of Q2 2026.
Medpace was a new Brevan Howard Capital Management position in Q2 2026.
Medpace made up 0.01% of Brevan Howard Capital Management's portfolio in Q2 2026, its #875 holding.
Brevan Howard Capital Management first reported a position in Medpace in Q4 2023 and has held it in 7 quarters since.
Brevan Howard Capital Management's Medpace position peaked at $3.86M in Q2 2025.
700 funds tracked by Wall St. Rank held Medpace as of Q2 2026.

Based on Brevan Howard Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.